본문 바로가기
KERD
논문KCI 등재

중국, 일본, 한국, WHO의 한약 자발적부작용보고체계 현황

Current Status of Spontaneous Adverse Reactions Reporting System on Herbal Medicine in China, Japan, Korea and WHO

2

조회

0

다운로드

11

인용

0

참고문헌

키워드

주제분류한의학

초록

Drugs may cause adverse effects, and spontaneous adverse drug reaction (ADR) reports have been used as the main method of drug safety evaluation after drugs have been released. The World Health Organization (WHO) collects ADR data reported from pharmacovigilance organizations in each nations. In China, pharmacovigilance centers operate with hierarchical structure at local, provincial and national levels. Also, Japan and Korea each operate their own respective independent pharmacovigilance organizations. WHO is collecting ADR reports for herbal medicine and 15~20% of all ADRs was related to herbal medicine in China. There are status reports of ADRs for herbal medicine in Japan as well. However, in Korea, there is no ADR reporting system regarding herbal medicine. In light of these overseas cases, a spontaneous ADR reporting system for herbal medicine in Korea should be necessary as well.

Abstract

Drugs may cause adverse effects, and spontaneous adverse drug reaction (ADR) reports have been used as the main method of drug safety evaluation after drugs have been released. The World Health Organization (WHO) collects ADR data reported from pharmacovigilance organizations in each nations. In China, pharmacovigilance centers operate with hierarchical structure at local, provincial and national levels. Also, Japan and Korea each operate their own respective independent pharmacovigilance organizations. WHO is collecting ADR reports for herbal medicine and 15~20% of all ADRs was related to herbal medicine in China. There are status reports of ADRs for herbal medicine in Japan as well. However, in Korea, there is no ADR reporting system regarding herbal medicine. In light of these overseas cases, a spontaneous ADR reporting system for herbal medicine in Korea should be necessary as well.

참고문헌 (31)

  1. 지제근, "알기쉬운 의학용어풀이집" (2009), 고려의학
  2. Lazarou J, "Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prosepctive studies", JAMA, 279, pp.1200~1205 (1998)
  3. Institute Of Medicine, "To Err is Human: Building a safer health system", pp.27~ (1999), National Academy Press
  4. Pirmohamed M, "Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients", BMJ, 329, pp.15~19 (2004)
  5. Bond CA, "Adverse drug reactions in United States hospitals", Pharmacotherapy, 26, pp.601~608 (2006)
  6. 박실비아, "외국의 의약품 부작용 피해구제제도 현황과 국내 실시 방안", 한국임상약학회지, 18(1), pp.18~27 (2008), 한국임상약학회
  7. Fletcher AP, "Spontaneous adverse drug reaction reporting vs event monitoring: a comparison", J R Soc Med, 84, pp.341~344 (1991)
  8. Gawert L, "The importance of patient perspective in drug survailance systems", Z Rheumatol, 69, pp.795~802 (2010)
  9. 박병주, "의약품 부작용 모니터링", 병원약사회지, 16, pp.99~107 (1999)
  10. 강휘중, "일본동양의학회지에 수록된 ‘부작용’에 관한 논문 분석 -한약 단독 투여시의 부작용-", 한국한의학연구원논문집, 17(2), pp.47~56 (2011), 한국한의학연구원
  11. 한약⋅생약, 한약제제 및 생약제제 부작용에 관련 보고체계 마련 및 활성화연구, "이선동", 식품의약품안전청, ~ (2007)
  12. Shaw D, "Toxicological risks of Chinese herbs", Planta Med, 76, pp.2012~2018 (2010)
  13. "About UMC"[URL]
  14. Zhang L, "Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: Current status and future perspective", J Ethnopharmacol, 140, pp.519~525 (2012)
  15. "CFDA releases 2012 Annual Report on National Adverse Drug Reaction Monitoring" (2013)[URL]
  16. "CFDA releases 2011 Annual Report on National Adverse Drug Reaction Monitoring" (2012)[URL]
  17. "Profile of Services 2012-201" (2013)[URL]
  18. "The Pharmaceuticals and Medical Devices Agency Annual Report FY 2011" (2011)[URL]
  19. "The Pharmaceuticals and Medical Devices Agency Annual Report FY 2005" (2005)[URL]
  20. 최돈웅, "우리나라의 의약품 안전관리 현황", 대한의사협회지, 55(9), pp.827~834 (2012), 대한의사협회
  21. "대한한의사협회"[URL]
  22. 의약품 안전성정보 보고동향 4호, "한국의약품안전관리원", ~ (2013)
  23. Sato A, "Pneumonitis induced by the herbal medicine Sho-saiko-to in Japan", Nihon Kyobu Shikkan Gakkai Zasshi, 35, pp.391~395 (1997)
  24. Haller CA, "Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids", NEJM, 343, pp.1686~1692 (2000)
  25. 이태호, "마황복용 후 사상체질별 이상반응에 관한 임상연구 : 무작위배정 이중맹검시험", 대한한방내과학회지, 30(1), pp.144~152 (2009), 대한한방내과학회
  26. 황우석, "기관지천식 환자에 대한 소청룡탕의 부작용에 대한 평가", 대한한방내과학회 추계학술대회지, pp.49~55 (2002)
  27. 권영주, "1개 대학 한방병원에서 EMR을 통해 보고된 한약에 의한 약물유해반응의 현황", 대한한방내과학회지, 33(4), pp.485~497 (2012), 대한한방내과학회

관련 논문AI추천

이 간행물의 다른 논문 (8건)